4.6 Article

Electrostatic contacts in the activator protein-1 coiled coil enhance stability predominantly by decreasing the unfolding rate

Journal

FEBS JOURNAL
Volume 276, Issue 24, Pages 7305-7318

Publisher

WILEY
DOI: 10.1111/j.1742-4658.2009.07440.x

Keywords

activator protein-1; coiled coils; electrostatic interactions; protein design; protein folding

Funding

  1. Royal Society [DBA4H00]
  2. University of Essex Biological Sciences Departmental Research Fund

Ask authors/readers for more resources

The hypothesis is tested that Jun-Fos activator protein-1 coiled coil interactions are dominated during late folding events by the formation of intricate intermolecular electrostatic contacts. A previously derived cJun-FosW was used as a template as it is a highly stable relative of the wild-type cJun-cFos coiled coil protein (thermal melting temperature = 63 degrees C versus 16 degrees C), allowing kinetic folding data to be readily extracted. An electrostatic mutant, cJun(R)-FosW(E), was created to generate six Arg-Glu interactions at e-g'+1 positions between cJun(R) and FosW(E), and investigations into how their contribution to stability is manifested in the folding pathway were undertaken. The evidence now strongly indicates that the formation of interhelical electrostatic contacts exert their effect predominantly on the coiled coil unfolding/dissociation rate. This has major implications for future antagonist design whereby kinetic rules could be applied to increase the residency time of the antagonist-peptide complex, and therefore significantly increase the efficacy of the antagonist.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

Sarah K. Madden, Aline Dantas de Araujo, Mara Gerhardt, David P. Fairlie, Jody M. Mason

Summary: Direct inhibition of c-Myc, a transcription factor overexpressed in many human cancers, has shown promising results in triggering tumor regression with reversible side effects. Challenges and lessons from current inhibitors are evaluated to explore future strategies for translating c-Myc inhibitors into clinical practice, such as miniaturisation of Omomyc and targeting E-box binding.

MOLECULAR CANCER (2021)

Article Chemistry, Medicinal

Designed β-Hairpins Inhibit LDH5 Oligomerization and Enzymatic Activity

Ferran Nadal-Bufi, Jody M. Mason, Lai Yue Chan, David J. Craik, Quentin Kaas, Sonia Troeira Henriques

Summary: Through rational and computer-based approaches, peptidic sequences with high affinity towards a beta-sheet region were identified and grafted into a cyclic cell-penetrating scaffold to inhibit LDH5 activity effectively. This approach of targeting an interface important for LDH5 function challenges the landscape of traditional small-molecule drug discovery programs.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Neurosciences

Oral (-)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β

Katriona L. Hole, Lydia E. Staniaszek, Gayathri Menon Balan, Jody M. Mason, Jon T. Brown, Robert J. Williams

Summary: Oral administration of EC reduces a specific phosphorylated form of tau in rTg4510 mice and inhibits its phosphorylation, independently of GSK3 beta regulation.

FRONTIERS IN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding

Richard M. Meade, Kathryn J. C. Watt, Robert J. Williams, Jody M. Mason

Summary: A peptide inhibitor was derived from a cell library screen to block aggregation of alpha-synuclein (α S) and its conversion into toxic species. Truncation and alanine scan analysis were used to determine inhibitory residues and improve peptide efficacy without disrupting α S lipid-binding. This work aims to develop a potent peptide antagonist of α S pathogenicity while preserving its native function.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Biochemistry & Molecular Biology

A Thermodynamic Model for Interpreting Tryptophan Excitation-Energy-Dependent Fluorescence Spectra Provides Insight Into Protein Conformational Sampling and Stability

A. Kwok, I. S. Camacho, S. Winter, M. Knight, R. M. Meade, M. W. Van der Kamp, A. Turner, J. O'Hara, J. M. Mason, A. R. Jones, V. L. Arcus, C. R. Pudney

Summary: This study introduces a thermodynamic model of the tryptophan red edge excitation shift (REES) effect, which can quantify the relationship between the REES effect and protein flexibility. The model is applied to various examples of different scales, demonstrating its potential for experimental measurement of the protein REES effect and integration with biomolecular simulation to gain new insights.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

Library-Derived Peptide Aggregation Modulators of Parkinson?s Disease Early-Onset ?-Synuclein Variants

Kathryn J. C. Watt, Richard M. Meade, Robert J. Williams, Jody M. Mason

Summary: This study identified five peptides that have inhibitory effects on the aggregation of Parkinson's disease (PD) related protein variants. These peptides not only reduce the aggregation of PD-associated proteins, but also show the same efficacy when incubated with other variants. Additionally, the optimized peptide 4554W(N6A) is highly effective against wild-type protein and several single-point mutant forms, providing a suitable baseline for further PD therapeutic research.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

In vitro single molecule and bulk phase studies reveal the AP-1 transcription factor cFos binds to DNA without its partner cJun br

James T. Leech, Andrew Brennan, Nicola A. Don, Jody M. Mason, Neil M. Kad

Summary: The AP-1 transcription factor family plays a crucial role in regulating the cell cycle and has various functions in proliferation, differentiation, and stress response. This study shows that cFos can bind to DNA independently of cJun and can interact with DNA as both monomers and dimers.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants

Jody M. Mason, Kathryn J. C. Watt, Richard M. Meade, Robert J. Williams

Summary: This article investigates the role of alpha-synuclein in synucleinopathies and explores the interplay between mutant alpha-synuclein and lipids.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Oncology

Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β

Emad Darvishi, Lila Ghamsari, Siok F. Leong, Ricardo Ramirez, Mark Koester, Erin Gallagher, Miao Yu, Jody M. Mason, Gene Merutka, Barry J. Kappel, Jim A. Rotolo

Summary: The study reveals the mechanism of action and antitumor activity of ST101, a novel peptide antagonist of C/EBP beta. ST101 inhibits dimerization of C/EBP beta and enhances its degradation, resulting in attenuation of transcription of C/EBP beta target genes and potent tumor-specific cytotoxic activity in various cancer cell lines. In mouse xenograft models, ST101 shows strong inhibition or regression of tumor growth, both as a single agent and in combination studies.

MOLECULAR CANCER THERAPEUTICS (2022)

Article Biochemistry & Molecular Biology

Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation

Ferran Nadal-Bufi, Lai Y. Chan, Hadi H. Mohammad, Jody M. Mason, Carlos Salomon, Andrew Lai, Erik W. Thompson, David J. Craik, Quentin Kaas, Sonia T. Henriques

Summary: This study reports the first peptide-based LDH5 inhibitor that can modulate cancer metabolism and kill glycolytic cancer cells. The study demonstrates the potential of using peptides as inhibitors of intracellular protein-protein interactions relevant for cancer pathways and shows that active peptides can be rationally designed to improve their cell permeation.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Chemistry, Multidisciplinary

An N-terminal alpha-synuclein fragment binds lipid vesicles to modulate lipid-induced aggregation

Richard M. Meade, Scott G. Allen, Christopher Williams, T. M. Simon Tang, Matthew P. Crump, Jody M. Mason

Summary: Misfolding and aggregation of alpha-synuclein (aS) into toxic conformations is involved in neurodegenerative diseases. This study demonstrates that a peptide based on the first 25 residues of aS can inhibit its aggregation process, providing a potential route for the treatment or prevention of these diseases.

CELL REPORTS PHYSICAL SCIENCE (2023)

Article Biochemistry & Molecular Biology

A library-derived peptide inhibitor of the BZLF1 transcription factor

Sarah K. Madden, Andrew Brennan, Jody M. Mason

Summary: Transcription factor dysregulation plays a key role in various diseases, and peptide-based inhibitors have shown potential in modulating protein-protein interactions. This study explores the use of a screening platform to identify a potent peptide inhibitor for the BZLF1 transcription factor. The library-derived peptide, AcidicW, demonstrates high stability and strong inhibition of BZLF1 function.

JOURNAL OF PEPTIDE SCIENCE (2023)

Article Chemistry, Multidisciplinary

The effect of helix-inducing constraints and downsizing upon a transcription block survival-derived functional cJun antagonist

Andrew Brennan, James T. Leech, Neil M. Kad, Jody M. Mason

Summary: The study developed a peptide antagonist that inhibits the activity of cJun through iterative truncation and side-chain cyclization. The resulting dual lactamized sequence is smaller and more stable in human serum, while maintaining high target affinity.

CELL REPORTS PHYSICAL SCIENCE (2022)

Article Chemistry, Multidisciplinary

An Approach to Derive Functional Peptide Inhibitors of Transcription Factor Activity

Andrew Brennan, James T. Leech, Neil M. Kad, Jody M. Mason

Summary: This study reports the development of a high-throughput screening platform for deriving functional transcription factor antagonists. The platform, called transcription block survival (TBS), can prevent cell proliferation by blocking RNA polymerase gene transcription. It enables rapid screening of libraries to identify potentially therapeutically valuable sequences.

JACS AU (2022)

Article Biochemistry & Molecular Biology

Combined computational and intracellular peptide library screening: towards a potent and selective Fra1 inhibitor

Miao Yu, Lila Ghamsari, Jim A. Rotolo, Barry J. Kappel, Jody M. Mason

Summary: The study focused on developing an antagonist selective for the Fra1 oncogenic transcriptional regulator using library design, computational screening, and intracellular screening. By reducing the library size and enriching for binders with specific criteria, the researchers identified a peptide (Fra1W) that exhibited specificity through a combination of hydrophobic and electrostatic contacts, showing high Fra1 affinity and selective binding. The multidisciplinary approach demonstrated a robust screening pipeline for generating target-specific hits and provided new insights into rational peptide design for novel bZIP family inhibitors.

RSC CHEMICAL BIOLOGY (2021)

No Data Available